sodium dehydrocholate

Suppliers

Names

[ CAS No. ]:
145-41-5

[ Name ]:
sodium dehydrocholate

[Synonym ]:
Dycholium
Dehydrocholic acid sodium salt
3,7,12-Trioxo-5b-cholan-24-oic Acid Monosodium Salt
Biliton
Biliron
3,7,12-Trioxo-5b-cholan-24-oic Acid Sodium Salt
Natriumdehydrocholat
Decholin sodium salt
sodium dehydrocholate
(5b)-3,7,12-Trioxocholan-24-oic Acid Sodium Salt
SodiuMDehydrocholic
Sodium (5β)-3,7,12-trioxocholan-24-oate
Carachol
dilabilsodium
decholinsodium
MFCD00150750
Sodium 3,7,12-Trioxo-5b-cholan-24-oate
Cholan-24-oic acid, 3,7,12-trioxo-, sodium salt, (5β)-
Sodium 3,7,12-triketocholanate
Dehydrocholate sodium
Sodium 3,7,12-Trioxo-5b-cholanate
dehydrocholic acid monosodium salt
Cholan-24-oic acid, 3,7,12-trioxo-, sodium salt, (5β)- (1:1)
Dilabil sodium
Sodium 3,7,12-trioxo-5β-cholan-24-oate
Decholin sodium
EINECS 205-652-1
decholinsodiumsalt
BILITON SODIUM SALT
Suprachol
Dehydrocholate (sodium)

Chemical & Physical Properties

[ Boiling Point ]:
581.5ºC at 760mmHg

[ Melting Point ]:
>300°C

[ Molecular Formula ]:
C24H33NaO5

[ Molecular Weight ]:
424.506

[ Flash Point ]:
319.5ºC

[ Exact Mass ]:
424.222565

[ PSA ]:
91.34000

[ LogP ]:
2.73860

[ Index of Refraction ]:
27 ° (C=5, H2O)

[ Water Solubility ]:
H2O: 0.1 M at 20 °C, clear, colorless

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
FZ2500000
CHEMICAL NAME :
5-beta-Cholan-24-oic acid, 3,7,12-trioxo-, sodium salt
CAS REGISTRY NUMBER :
145-41-5
LAST UPDATED :
199701
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C24-H33-O5.Na
MOLECULAR WEIGHT :
424.56

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3755 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
GWXXBX German Offenlegungsschrift Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2630169
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CHTPBA Chimica Therapeutica. (Paris, France) V.1-8, 1965-73. For publisher information, see EJMCA5. Volume(issue)/page/year: 5,188,1970
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2300 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
YOIZA3 Yonago Igaku Zasshi. Journal of the Yonago Medical Association. (c/o Tottori Daigaku Igakabu, 86 Nishi-machi, Yonago, Japan) V.1- 1948- Volume(issue)/page/year: 25,70,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
887 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
RPOBAR Research Progress in Organic-Biological and Medicinal Chemistry. (New York, NY) V.1-3, 1964-72. Discontinued. Volume(issue)/page/year: 2,280,1970
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2150 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
YOIZA3 Yonago Igaku Zasshi. Journal of the Yonago Medical Association. (c/o Tottori Daigaku Igakabu, 86 Nishi-machi, Yonago, Japan) V.1- 1948- Volume(issue)/page/year: 25,70,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1480 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
RPOBAR Research Progress in Organic-Biological and Medicinal Chemistry. (New York, NY) V.1-3, 1964-72. Discontinued. Volume(issue)/page/year: 2,280,1970
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1350 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
YOIZA3 Yonago Igaku Zasshi. Journal of the Yonago Medical Association. (c/o Tottori Daigaku Igakabu, 86 Nishi-machi, Yonago, Japan) V.1- 1948- Volume(issue)/page/year: 25,70,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1100 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
YOIZA3 Yonago Igaku Zasshi. Journal of the Yonago Medical Association. (c/o Tottori Daigaku Igakabu, 86 Nishi-machi, Yonago, Japan) V.1- 1948- Volume(issue)/page/year: 25,70,1974
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Cardiac - other changes Gastrointestinal - other changes Blood - other changes
REFERENCE :
ZGEMAZ Zeitschrift fuer die Gesamte Experimentelle Medizin. (Berlin, Fed. Rep. Ger.) V.1-139, 1913-65. For publisher information, see REXMAS. Volume(issue)/page/year: 52,779,1926

Safety Information

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
R22

[ Safety Phrases ]:
S22-S36

[ WGK Germany ]:
3

[ RTECS ]:
FZ2500000


Related Compounds

  • sodium,(Z)-4-[(2-amino-3-methylbutanoyl)amino]-3-chloro-5-hydroxy-5-oxopent-2-enoate
  • sodium lauroamphoacetate
  • sodium 2,8,8-trimethyl-3-oxo-1,7-diaza-4-oxabicyclo<3.2.1>octane-6-carboxylate
  • sodium 2-ethylhexanolate
  • sodium boron(-1) anion
  • sodium 5-chloro-3-[(1,5-dihydroxy-2-naphthyl)azo]-2-hydroxybenzenesulphonate
  • N-(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-1H-indole-5-carboxamide
  • N-(4-(3-(trifluoromethyl)phenoxy)but-2-yn-1-yl)pyridine-3-sulfonamide
  • N-(2-(3-cyclopropyl-5-oxo-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)ethyl)-2,4-dimethylthiazole-5-carboxamide
  • N-(2-(3-cyclopropyl-5-oxo-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)ethyl)-2,5-dimethylfuran-3-carboxamide
  • 5-methoxy-6-(2-(piperazin-1-yl)ethoxy)-1H-indole
  • 2-methoxy-N-(4-(3-(trifluoromethyl)phenoxy)but-2-yn-1-yl)benzenesulfonamide
  • N-[2-(1H-benzimidazol-1-yl)ethyl]-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]propanamide
  • N-(2-(3-cyclopropyl-5-oxo-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)ethyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide
  • N-(2-(3-cyclopropyl-5-oxo-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)ethyl)benzo[d]thiazole-2-carboxamide
  • N-(2-(3-cyclopropyl-5-oxo-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)ethyl)-2-(2,5-dioxopyrrolidin-1-yl)acetamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.